$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb

$areb Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223028583 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$3.346M	$3.671M	$338.7K
YoY Change	-18.46%	983.7%	66.38%
Cost Of Revenue	$3.095M	$2.983M	$241.1K
YoY Change	-0.94%	1137.23%	43.0%
Gross Profit	$250.1K	$687.9K	$97.63K
YoY Change	-74.43%	604.6%	179.01%
Gross Profit Margin	7.48%	18.74%	28.82%
Selling, General & Admin	$2.617M	$2.041M	$1.419M
YoY Change	-0.1%	43.84%	22.49%
% of Gross Profit	1046.11%	296.68%	1453.3%
Research & Development	$20.33K		$113.2K
YoY Change			-22.65%
% of Gross Profit	8.13%		115.94%
Depreciation & Amortization	$29.26K	$25.28K	$460.00
YoY Change	194.07%	5395.65%	142.11%
% of Gross Profit	11.7%	3.68%	0.47%
Operating Expenses	$3.179M	$2.239M	$1.682M
YoY Change	15.68%	33.12%	23.42%
Operating Profit	-$2.929M	-$1.551M	-$1.584M
YoY Change	65.46%	-2.1%	19.31%
Interest Expense	$95.33K	$148.4K	$18.00K
YoY Change	201.83%	724.6%	-96.84%
% of Operating Profit
Other Income/Expense, Net	$135.4K	$1.108M
YoY Change	-135.91%
Pretax Income	-$2.794M	-$590.2K	-$1.602M
YoY Change	30.1%	-63.16%	-36.82%
Income Tax
% Of Pretax Income
Net Earnings	-$2.794M	-$590.2K	-$1.602M
YoY Change	30.1%	-63.16%	-36.82%
Net Earnings / Revenue	-83.5%	-16.08%	-473.0%
Basic Earnings Per Share	-$0.95	-$0.87	-$0.34
Diluted Earnings Per Share	-$0.95	-$0.87	-$337.9K
COMMON SHARES
Basic Shares Outstanding	2.842M shares	16.93M shares	4.741M shares
Diluted Shares Outstanding	2.931M shares	679.0K shares	126.8K shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.633M	$2.733M	$2.510M
YoY Change	37.76%	8.9%	838.77%
Cash & Equivalents	$1.633M	$2.733M	$2.510M
Short-Term Investments
Other Short-Term Assets	$166.1K	$160.3K	$529.5K
YoY Change	12.39%	-69.73%	666.38%
Inventory	$8.821M	$8.874M	$1.051M
Prepaid Expenses	$166.1K	$160.3K	$529.5K
Receivables	$2.631M	$1.982M	$273.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$13.25M	$13.75M	$4.364M
YoY Change	28.45%	215.09%	252.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$377.3K	$402.2K	$13.20K
YoY Change	-22.38%	2947.57%	379.85%
Goodwill	$4.525M	$4.200M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.822M	$5.716M	$4.750K
YoY Change	37.97%	120245.07%
Total Long-Term Assets	$6.199M	$6.119M	$17.95K
YoY Change	31.73%	33994.21%	552.58%
TOTAL ASSETS
Total Short-Term Assets	$13.25M	$13.75M	$4.364M
Total Long-Term Assets	$6.199M	$6.119M	$17.95K
Total Assets	$19.45M	$19.87M	$4.382M
YoY Change	29.48%	353.44%	253.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.174M	$2.289M	$530.6K
YoY Change	-5.98%	331.38%	-23.79%
Accrued Expenses	$827.1K	$1.069M	$67.92K
YoY Change	1117.7%	1474.57%	-85.94%
Deferred Revenue
YoY Change
Short-Term Debt	$1.153M	$1.482M	$605.0K
YoY Change	90.94%	145.02%	-84.71%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.938M	$6.347M	$1.208M
YoY Change	98.74%	425.39%	-76.49%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$439.5K	$521.7K
YoY Change
Total Long-Term Liabilities	$439.5K	$521.7K	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.938M	$6.347M	$1.208M
Total Long-Term Liabilities	$439.5K	$521.7K	$0.00
Total Liabilities	$6.378M	$6.868M	$1.208M
YoY Change	113.45%	468.59%	-77.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$37.72M	-$34.93M	-$31.20M
YoY Change	13.12%	11.96%
Common Stock	$5.875K	$749.00	$4.741K
YoY Change	-30.67%	-84.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.07M	$13.00M	$3.174M
YoY Change
Total Liabilities & Shareholders Equity	$19.45M	$19.87M	$4.382M
YoY Change	29.48%	353.44%	253.42%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$2.794M	-$590.2K	-$1.602M
YoY Change	30.1%	-63.16%	-36.82%
Depreciation, Depletion And Amortization	$29.26K	$25.28K	$460.00
YoY Change	194.07%	5395.65%	142.11%
Cash From Operating Activities	-$3.619M	-$784.3K	-$979.6K
YoY Change	78.86%	-19.93%	518.03%
INVESTING ACTIVITIES
Capital Expenditures			-$13.65K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$273.6K	$1.400K	-$13.65K
YoY Change	-97.33%	-110.26%
Cash From Investing Activities	-$273.6K	$1.400K	-$13.65K
YoY Change	-97.33%	-110.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.789M	3.050M	-5.480K
YoY Change	-74.52%	-55760.95%	-101.41%
NET CHANGE
Cash From Operating Activities	-3.619M	-784.3K	-979.6K
Cash From Investing Activities	-273.6K	1.400K	-13.65K
Cash From Financing Activities	2.789M	3.050M	-5.480K
Net Change In Cash	-1.104M	2.267M	-998.7K
YoY Change	-16.68%	-327.02%	-532.77%
FREE CASH FLOW
Cash From Operating Activities	-$3.619M	-$784.3K	-$979.6K
Capital Expenditures			-$13.65K
Free Cash Flow			-$965.9K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001648087
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2022Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent		usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q2	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense		usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2022Q2	AREB	Employee Retention Credit Funds Net Of Costs To Collect EmployeeRetentionCreditFundsNetOfCostsToCollect		usd
	AREB	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense		usd
	AREB	Employee Retention Credit Funds Net Of Costs To Collect EmployeeRetentionCreditFundsNetOfCostsToCollect		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt		usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt		usd
	AREB	Proceeds From Working Capital Loan Preexisting Lender ProceedsFromWorkingCapitalLoanPreexistingLender		usd
	AREB	Principal Payments On Working Capital Loan Preexisting Lender PrincipalPaymentsOnWorkingCapitalLoanPreexistingLender		usd
	AREB	Repayments Of Non Related Party Debt RepaymentsOfNonRelatedPartyDebt		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	AREB	Debt Repayment Through Issuance Of Common Stock DebtRepaymentThroughIssuanceOfCommonStock		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodTotalIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodTotalIntrinsicValue		usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
	AREB	Total Finance Lease Expense TotalFinanceLeaseExpense		usd
	AREB	Total Finance Lease Expense TotalFinanceLeaseExpense		usd
	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear		usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths		usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo		usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree		usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		usd
CY2023Q2	AREB	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour		usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue		usd
CY2023Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability		usd
CY2023Q2	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LiabilitiesCurrent
CY2023Q2	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LiabilitiesCurrent
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41267
	dei	Entity Registrant Name EntityRegistrantName	AMERICAN REBEL HOLDINGS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3892903
	dei	Entity Address Address Line1 EntityAddressAddressLine1	909 18th Avenue South
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite A
	dei	Entity Address City Or Town EntityAddressCityOrTown	Nashville
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37212
	dei	City Area Code CityAreaCode	(833)
	dei	Local Phone Number LocalPhoneNumber	267-3235
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2842311	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2733253	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	356754	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	1982483	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1613489	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	160295	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	207052	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8563465	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7421696	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	310587	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	309684	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	13750083	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9908675	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	402157	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	456525	usd
CY2023Q2	us-gaap	Deposit Assets DepositAssets	29120	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	18032	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1487271	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1977329	usd
CY2023Q2	us-gaap	Goodwill Goodwill	4200000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4200000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5716391	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6195361	usd
CY2023Q2	us-gaap	Assets Assets	19868630	usd
CY2022Q4	us-gaap	Assets Assets	16560561	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2288920	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	2523551	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	103919	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	103919	usd
CY2023Q2	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	146000	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	1482449	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	602643	usd
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1359683	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	965529	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	992496	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6346500	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4222609	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	521742	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	984833	usd
CY2023Q2	us-gaap	Liabilities Liabilities	6868242	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5207442	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	175000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	175000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	175000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	175000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	748720	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	748720	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	677221	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	677221	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	749	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	677	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	47929533	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	45465077	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34930069	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34112810	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13000388	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11353119	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19868630	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16560561	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3670571	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	338706	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	2982688	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	241078	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	687883	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	97628	usd
CY2023Q2	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	931505	usd
CY2022Q2	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	246407	usd
CY2023Q2	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense	275474	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	113190	usd
CY2023Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	172617	usd
CY2022Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	149249	usd
CY2023Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	833851	usd
CY2022Q2	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1172418	usd
CY2023Q2	AREB	Depreciation And Amortization Expense DepreciationAndAmortizationExpense	25275	usd
CY2022Q2	AREB	Depreciation And Amortization Expense DepreciationAndAmortizationExpense	455	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2238722	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	1681719	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1550839	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1584091	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	148437	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	18001	usd
CY2023Q2	AREB	Employee Retention Credit Funds Net Of Costs To Collect EmployeeRetentionCreditFundsNetOfCostsToCollect	1107672	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1400	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-590204	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1602092	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-590204	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1602092	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.87
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.87
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-20.75
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-20.75
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	679000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	679000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126760	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126760	shares
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8072670	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	492786	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5774014	usd
	us-gaap	Cost Of Revenue CostOfRevenue	337797	usd
	us-gaap	Gross Profit GrossProfit	2298656	usd
	us-gaap	Gross Profit GrossProfit	154989	usd
	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	1876104	usd
	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	709396	usd
	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense	502134	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16495	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	146463	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	425342	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	230219	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1195000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1610723	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	54365	usd
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	1355	usd
	us-gaap	Operating Expenses OperatingExpenses	4069440	usd
	us-gaap	Operating Expenses OperatingExpenses	2698156	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1770784	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2543167	usd
	us-gaap	Interest Expense InterestExpense	155547	usd
	us-gaap	Interest Expense InterestExpense	310406	usd
	AREB	Employee Retention Credit Funds Net Of Costs To Collect EmployeeRetentionCreditFundsNetOfCostsToCollect	1107672	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1400	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1376756	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-817259	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4230329	usd
	us-gaap	Net Income Loss NetIncomeLoss	-817259	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4230329	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-33.37
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-33.37
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	678000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	678000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126760	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126760	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4170337	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9038456	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	969535	usd
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	1566559	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4230329	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3173844	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11353119	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11353119	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	312452	usd
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	615000	shares
CY2023Q2	AREB	Sale Of Prefunded Stock Price Per Share SaleOfPrefundedStockPricePerShare	4.36
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
	AREB	Adjustments To Additional Paid In Capital Sale Of Prefunded Common Stock Warrants AdjustmentsToAdditionalPaidInCapitalSaleOfPrefundedCommonStockWarrants	2681400	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-529324	usd
	us-gaap	Net Income Loss NetIncomeLoss	-817259	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13000388	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	13000388	usd
	us-gaap	Net Income Loss NetIncomeLoss	-817259	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4230329	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	54365	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1355	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1400	usd
	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	969535	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1000457	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	368993	usd
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	172307	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-46756	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	469295	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1142671	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	140639	usd
	AREB	Increase Decrease In Inventory Deposits IncreaseDecreaseInInventoryDeposits	11087	usd
	AREB	Increase Decrease In Inventory Deposits IncreaseDecreaseInInventoryDeposits	224894	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-234630	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-637706	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2474919	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3903823	usd
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	-1402	usd
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	13651	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1402	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13651	usd
	AREB	Payments Of Net Offering Costs PaymentsOfNetOfferingCosts	529324	usd
	AREB	Payments Of Net Offering Costs PaymentsOfNetOfferingCosts	1461544	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2464528	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9038456	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1700000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	146000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-81506	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	340317	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	1000000	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	117800	usd
	AREB	Proceeds From Working Capital Loan Preexisting Lender ProceedsFromWorkingCapitalLoanPreexistingLender	60000	usd
	AREB	Principal Payments On Working Capital Loan Preexisting Lender PrincipalPaymentsOnWorkingCapitalLoanPreexistingLender	2395	usd
	AREB	Repayments Of Non Related Party Debt RepaymentsOfNonRelatedPartyDebt	2607108	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4850016	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6409842	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2376499	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2492368	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	356754	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17607	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2733253	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2509975	usd
	us-gaap	Interest Paid Net InterestPaidNet	156252	usd
	us-gaap	Interest Paid Net InterestPaidNet	206607	usd
	AREB	Debt Repayment Through Issuance Of Common Stock DebtRepaymentThroughIssuanceOfCommonStock	1950224	usd
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2014-12-15
	us-gaap	Fiscal Period FiscalPeriod	<p id="xdx_844_eus-gaap--FiscalPeriod_znsTol8f1jAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zOu7pF3S1UUi">Year-end</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s year-end is December 31.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.25
CY2022Q4	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	15099	shares
CY2023Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	172617	usd
CY2022Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	149249	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	425342	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	230219	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.87
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.87
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-20.75
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-20.75
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-33.37
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-33.37
	AREB	Shares Used In Computation Of Basic Earnings Per Share SharesUsedInComputationOfBasicEarningsPerShare	678000	shares
	AREB	Shares Used In Computation Of Basic Earnings Per Share SharesUsedInComputationOfBasicEarningsPerShare	126760	shares
	AREB	Total Dilutive Effect Of Outstanding Stock Awards Or Common Stock Equivalents TotalDilutiveEffectOfOutstandingStockAwardsOrCommonStockEquivalents	1078	shares
	AREB	Total Dilutive Effect Of Outstanding Stock Awards Or Common Stock Equivalents TotalDilutiveEffectOfOutstandingStockAwardsOrCommonStockEquivalents	75500	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1756000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	202260	shares
	us-gaap	Net Income Loss NetIncomeLoss	-817259	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4230329	usd
	AREB	Fully Diluted Income Loss Per Share FullyDilutedIncomeLossPerShare	0.47
	AREB	Fully Diluted Income Loss Per Share FullyDilutedIncomeLossPerShare	20.92
	us-gaap	Payments For Rent PaymentsForRent	453000	usd
	us-gaap	Payments For Rent PaymentsForRent	0	usd
	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	less than a 50% likelihood
CY2022	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	less than a 50% likelihood
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_845_eus-gaap--UseOfEstimates_zIFAa8qkGUu9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zuz6SKbo9LR">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	AREB	Warrant Liabilities WarrantLiabilities	93458	usd
	AREB	Warrant Liabilities WarrantLiabilities	99238	usd
	us-gaap	Net Income Loss NetIncomeLoss	-817259	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4230329	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34930069	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34112810	usd
CY2023Q2	AREB	Working Capital Deficit WorkingCapitalDeficit	7403583	usd
CY2022Q4	AREB	Working Capital Deficit WorkingCapitalDeficit	6678562	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8563465	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7421696	usd
CY2023Q2	AREB	Inventory Deposits InventoryDeposits	310587	usd
CY2022Q4	AREB	Inventory Deposits InventoryDeposits	309684	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	8874052	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7731380	usd
CY2022Q4	us-gaap	Deposits Deposits	600000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	790832	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	815859	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	388675	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	359334	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	402157	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	456525	usd
	us-gaap	Depreciation Depreciation	54365	usd
	us-gaap	Depreciation Depreciation	1355	usd
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1359683	usd
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1359683	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	1482449	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	602643	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	1482449	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	602643	usd
CY2023Q2	us-gaap	Secured Debt SecuredDebt	1482449	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	602643	usd
CY2023Q2	us-gaap	Goodwill Goodwill	4200000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4200000	usd
CY2023Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	4200000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	4200000	usd
CY2023Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	34930069	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	34112810	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7335000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7163690	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7335000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7163690	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7335000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7163690	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7335000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7163690	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Explanation Of Change ValuationAllowanceDeferredTaxAssetExplanationOfChange	As a result, management determined it was more likely than not deferred tax assets will not be realized as of June 30, 2023, and December 31, 2022, and recognized 100% valuation allowance for each period.
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.000	pure
	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.210	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022Q3	AREB	Corporate Alternative Minimum Income Tax Rate CorporateAlternativeMinimumIncomeTaxRate	0.15	pure
CY2022Q3	AREB	Percentage Ogexcise Tax On Corporate Stock Repurchases PercentageOgexciseTaxOnCorporateStockRepurchases	0.01	pure
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-25
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	The June 30, 2023 share numbers do not reflect any adjustment due to the 100-share round lot rounding up that has been inherent in the Company’s reverse stock splits since 2022. A shareholder that held a minimum of 100 shares pre-reverse split, based on the reverse stock split now holds less than 100 shares of our common stock will be issued an additional number of shares to ensure that they continue to maintain at least 100 shares of our common stock in ownership.
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1000000	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	129.6875
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1566659.00	usd
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	15099	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	15099	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	129.6875
CY2022Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	12887976.31	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	20372	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	448096	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	27.50
CY2023Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	2993850.63	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	71499	shares
CY2023Q2	us-gaap	Share Price SharePrice	4.37
CY2023Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	615000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.37
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.25
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	448096	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	448096	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	28072	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	220.00
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y11M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	116386	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	129.6875
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P5Y
CY2022	AREB	Share Based Payment Award Options Granted Debt Conversion ShareBasedPaymentAwardOptionsGrantedDebtConversion	15099	shares
CY2022	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Granted Debt Conversion Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantedDebtConversionExercisePrice	129.6875
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Granted Debt Conversion Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualGrantedDebtConversionTerm2	P5Y
CY2022	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Warrant ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWarrant	463195	shares
CY2022	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Warrant Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageWarrantExercisePrice	0.25
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Warrant Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualWarrantTerm2	P5Y
CY2022	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOne	936937	shares
CY2022	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price One ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceOne	21.50
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P5Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	463195	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.25
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	38	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1096455	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	30.50
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	1301499	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.37
	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P5Y
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.01
	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Exercised Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageExercisedRemainingContractualTerm2	P5Y
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2397954	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.50
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M
	AREB	Rent Expense For Operating Leases RentExpenseForOperatingLeases	453320	usd
	AREB	Rent Expense For Operating Leases RentExpenseForOperatingLeases	0	usd
	AREB	Rental Equipment Expense For Finance Leases RentalEquipmentExpenseForFinanceLeases	0	usd
	AREB	Rental Equipment Expense For Finance Leases RentalEquipmentExpenseForFinanceLeases	0	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	453320	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	453320	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1487271	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	490058	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2023Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0500	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0500	pure
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	596892	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	688526	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	163794	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	62792	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3733	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1515737	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	85257	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1430480	usd
CY2023Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	0	usd
CY2022Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	0	usd
CY2023Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1359683	usd

Files In Submission

Name	View Source	Status
areb-20230630_def.xml	Edgar Link	unprocessable
form10q_htm.xml	Edgar Link	completed
0001493152-23-028583-index-headers.html	Edgar Link	pending
0001493152-23-028583-index.html	Edgar Link	pending
0001493152-23-028583.txt	Edgar Link	pending
0001493152-23-028583-xbrl.zip	Edgar Link	pending
areb-20230630.xsd	Edgar Link	pending
ex10-16.htm	Edgar Link	pending
ex10-16_001.jpg	Edgar Link	pending
ex10-16_002.jpg	Edgar Link	pending
ex10-16_003.jpg	Edgar Link	pending
ex10-16_004.jpg	Edgar Link	pending
ex10-16_005.jpg	Edgar Link	pending
ex10-16_006.jpg	Edgar Link	pending
ex10-16_007.jpg	Edgar Link	pending
ex10-16_008.jpg	Edgar Link	pending
ex10-16_009.jpg	Edgar Link	pending
ex10-16_010.jpg	Edgar Link	pending
ex10-16_011.jpg	Edgar Link	pending
ex10-16_012.jpg	Edgar Link	pending
ex10-16_013.jpg	Edgar Link	pending
ex10-16_014.jpg	Edgar Link	pending
ex10-16_015.jpg	Edgar Link	pending
ex10-16_016.jpg	Edgar Link	pending
ex10-16_017.jpg	Edgar Link	pending
ex10-16_018.jpg	Edgar Link	pending
ex10-17.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
areb-20230630_cal.xml	Edgar Link	unprocessable
areb-20230630_lab.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
areb-20230630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb

2023 Q3 Form 10-Q Financial Statement

#000149315223028583 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREB AMERICAN REBEL HOLDINGS INC Stock $areb

2023 Q3 Form 10-Q Financial Statement

#000149315223028583 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb